PRO-LAD
6-Propyl-nor-LSD
9,10-Didehydro-6-propyl-N,N-diethylergoline-8β-carboxamide
6-Norlysergamide, N,N-diethyl-6-propyl
N,N-Diethylnorlysergamide, 6-propyl
6-Propylnorlysergamide, N,N-diethyl
N,N-Diethyl-6-propyl-6-norlysergamide
 
(8β)-N,N-Diethyl-6-propyl-9,10-didehydroergoline-8-carboxamide
 5051 ·  C22H29N3O ·  351.485
 InChI=1S/C22H29N3O/c1-4-10-25-14-16(22(26)24(5-2)6-3)11-18-17-8-7-9-19-21(17)15(13-23-19)12-20(18)25/h7-9,11,13,16,20,23H,4-6,10,12,14H2,1-3H3/t16-,20-/m1/s1
 HZKYLVLOBYNKKM-OXQOHEQNSA-N This stereoisomer Any stereoisomer
 CCCN1C[C@@H](C=C2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(CC)CC

Hoffman, AJ; Nichols, DE. Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives. J. Med. Chem., 1 Sep 1985, 28 (9), 1252–1255. 583 kB. https://doi.org/10.1021/jm00147a022

Nichols, DE. Psychedelics. Pharmacol. Rev., 1 Apr 2016, 68 (2), 264-355. 1.9 MB. https://doi.org/10.1124/pr.115.011478 Updated with published correction to Figure 4 (the α-methyl group was missing in the original)

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 2003; pp 67–137. 6.3 MB.

Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1994; pp 74–91. 51 kB.

Hoffman, AJ. Synthesis and pharmacological evaluation of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives. Ph. D. Thesis, Purdue University, 1 Aug 1987. 9.3 MB. #3

N-Hexyllysergamide
N-Hexan-2-yllysergamide
N,N-Dipropyllysergamide
DIPLA · N,N-Diisopropyllysergamide
(C4)-AKB48
N-sec-Butyl-N-methyllysergamide
IPR-LAD
16 November 2018 · Creative Commons BY-NC-SA ·